aHZ RR (95% CrI) | bHZ-Complications RR (95% CrI) | bHZ-Recurrence RR (95% CrI) | ||
---|---|---|---|---|
IC | IC-free | 1 | 1 | 1 |
IC | 1.51 (1.48–1.54) | 2.37 (2.01–2.8) | 1.25 (1.19–1.31) | |
SEX | Man | 1 | 1 | 1 |
Woman | 1.33 (1.31–1.35) | 1.15 (0.98–1.35) | 1.19 (1.14–1.24) | |
AGE | 18–29 | 1 | 1 | 1 |
30–39 | 1.06 (1.02–1.09) | 5.62 (2.63–11.99) | 1.08 (0.95–1.23) | |
40–49 | 1.24 (1.2–1.29) | 9.71 (4.9–19.24) | 1.14 (1.01–1.28) | |
50–59 | 2.42 (2.35–2.5) | 7.74 (3.95–15.16) | 1.21 (1.08–1.36) | |
60–69 | 3.43 (3.32–3.54) | 12.3 (6.84–22.1) | 1.52 (1.36–1.7) | |
70–79 | 3.72 (3.61–3.85) | 26.14 (14.72–46.44) | 1.9 (1.7–2.12) | |
≥ 80 | 3.57 (3.45–3.7) | 39.72 (22.5–70.12) | 2.14 (1.91–2.4) | |
COMORBIDITIES | ||||
COPD | NO-COPD | 1 | 1 | 1 |
COPD | 1.36 (1.32–1.4) | 2.54 (2.11–3.06) | 1.26 (1.17–1.35) | |
DIABETES | NO-DIABETES | 1 | 1 | 1 |
DIABETES | 1.12 (1.09–1.14) | 1.07 (0.89–1.28) | 1.05 (1–1.11) | |
HF | NO-HF | 1 | 1 | 1 |
HF | 1.16 (1.11–1.21) | 2.07 (1.68–2.55) | 1.63 (1.39–1.9) | |
CKD | NO-CKD | 1 | 1 | 1 |
CKD | 1.18 (1.13–1.23) | 1.63 (1.31–2.03) | 1.2 (1.09–1.33) |